Immediate Impact
6 from Science/Nature 77 standout
Citing Papers
Effectiveness of nirsevimab immunoprophylaxis against respiratory syncytial virus-related outcomes in hospital and primary care settings: a retrospective cohort study in infants in Catalonia (Spain)
2024 Standout
Impact of nirsevimab prophylaxis on paediatric respiratory syncytial virus (RSV)-related hospitalisations during the initial 2023/24 season in Luxembourg
2024 Standout
Works of Simon Royal being referenced
Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants
2023 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Simon Royal | 175 | 123 | 83 | 490 | 170 | 17 | 960 | |
| Balamurugan Tangiisuran | 99 | 93 | 52 | 510 | 181 | 55 | 1.0k | |
| Laurie L. Briceland | 169 | 140 | 41 | 361 | 65 | 52 | 998 | |
| Ingebjørg Buajordet | 219 | 64 | 42 | 257 | 149 | 17 | 815 | |
| Louise Mallet | 86 | 87 | 46 | 523 | 66 | 49 | 1.2k | |
| Balthasar L. Hug | 204 | 77 | 35 | 251 | 87 | 40 | 872 | |
| H. J. M. Beijer | 57 | 43 | 52 | 374 | 208 | 23 | 819 | |
| Sarah Rodgers | 99 | 316 | 120 | 497 | 52 | 40 | 1.1k | |
| A.W. Lenderink | 52 | 62 | 139 | 446 | 164 | 20 | 1.2k | |
| Emma Davies | 125 | 56 | 23 | 447 | 428 | 22 | 1.0k | |
| Angela B. Hoth | 132 | 190 | 18 | 753 | 70 | 13 | 1.1k |
All Works
Login with ORCID to disown or claim papers
Loading papers...